149 related articles for article (PubMed ID: 28486308)
1. Effect of N-Desalkylquetiapine/Quetiapine Plasma Level Ratio on Anxiety and Depression in Bipolar Disorder: A Prospective Observational Study.
Rovera C; Mauri MC; Di Pace C; Paletta S; Reggiori A; Ciappolino V; Cattaneo D; Baldelli S; Clementi E; Altamura AC
Ther Drug Monit; 2017 Aug; 39(4):441-445. PubMed ID: 28486308
[TBL] [Abstract][Full Text] [Related]
2. Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach: a prospective observational study.
Altamura AC; Moliterno D; Paletta S; Buoli M; Dell'osso B; Mauri MC; Bareggi SR
Clin Drug Investig; 2012 Mar; 32(3):213-9. PubMed ID: 22299714
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic variability of quetiapine and the active metabolite N-desalkylquetiapine in psychiatric patients.
Bakken GV; Rudberg I; Molden E; Refsum H; Hermann M
Ther Drug Monit; 2011 Apr; 33(2):222-6. PubMed ID: 21383647
[TBL] [Abstract][Full Text] [Related]
4. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL
Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438
[TBL] [Abstract][Full Text] [Related]
5. The quetiapine active metabolite N-desalkylquetiapine and the neurotensin NTS₁ receptor agonist PD149163 exhibit antidepressant-like effects on operant responding in male rats.
Hillhouse TM; Shankland Z; Matazel KS; Keiser AA; Prus AJ
Exp Clin Psychopharmacol; 2014 Dec; 22(6):548-56. PubMed ID: 25285844
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
Calabrese JR; Keck PE; Macfadden W; Minkwitz M; Ketter TA; Weisler RH; Cutler AJ; McCoy R; Wilson E; Mullen J
Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of quetiapine, N-desalkylquetiapine, o-desalkylquetiapine, 7-hydroxyquetiapine, and quetiapine sulfoxide in relation to quetiapine dose, formulation, and other factors.
Fisher DS; Handley SA; Flanagan RJ; Taylor DM
Ther Drug Monit; 2012 Aug; 34(4):415-21. PubMed ID: 22777152
[TBL] [Abstract][Full Text] [Related]
8. The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice.
Shajahan P; Taylor M
J Psychopharmacol; 2010 Apr; 24(4):565-72. PubMed ID: 19164493
[TBL] [Abstract][Full Text] [Related]
9. [Quetiapin in bipolar disorders].
Sümegi A
Neuropsychopharmacol Hung; 2008 Dec; 10(5):281-91. PubMed ID: 19419014
[TBL] [Abstract][Full Text] [Related]
10. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
Calabrese JR; Elhaj O; Gajwani P; Gao K
J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
[TBL] [Abstract][Full Text] [Related]
11. Impact of genetic variability in CYP2D6, CYP3A5, and ABCB1 on serum concentrations of quetiapine and N-desalkylquetiapine in psychiatric patients.
Bakken GV; Molden E; Hermann M
Ther Drug Monit; 2015 Apr; 37(2):256-61. PubMed ID: 25254417
[TBL] [Abstract][Full Text] [Related]
12. Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR.
Nyberg S; Jucaite A; Takano A; Kågedal M; Cselényi Z; Halldin C; Farde L
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2235-44. PubMed ID: 23809226
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
McIntyre RS; Muzina DJ; Adams A; Lourenco MT; Law CW; Soczynska JK; Woldeyohannes HO; Nathanson J; Kennedy SH
Expert Opin Pharmacother; 2009 Dec; 10(18):3061-75. PubMed ID: 19954275
[TBL] [Abstract][Full Text] [Related]
14. Bipolar depression: a new role for atypical antipsychotics?
Keck PE
Bipolar Disord; 2005; 7 Suppl 4():34-40. PubMed ID: 15948765
[TBL] [Abstract][Full Text] [Related]
15. Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder.
Bauer M; Thase ME; Liu S; Earley W; Eriksson H
J Psychopharmacol; 2015 May; 29(5):565-74. PubMed ID: 25257148
[TBL] [Abstract][Full Text] [Related]
16. A Positron Emission Tomography Study of Norepinephrine Transporter Occupancy and Its Correlation with Symptom Response in Depressed Patients Treated with Quetiapine XR.
Yatham LN; Sossi V; Ding YS; Vafai N; Arumugham SS; Dhanoa T; Lam RW; Bond DJ; Puyat JH
Int J Neuropsychopharmacol; 2018 Feb; 21(2):108-113. PubMed ID: 29016993
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W;
Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine extended release: preliminary evidence of a rapid onset of the antidepressant effect in bipolar depression.
Porcelli S; Balzarro B; de Ronchi D; Serretti A
J Clin Psychopharmacol; 2014 Jun; 34(3):303-6. PubMed ID: 24743712
[TBL] [Abstract][Full Text] [Related]
19. Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder.
Nierenberg AA; McElroy SL; Friedman ES; Ketter TA; Shelton RC; Deckersbach T; McInnis MG; Bowden CL; Tohen M; Kocsis JH; Calabrese JR; Kinrys G; Bobo WV; Singh V; Kamali M; Kemp D; Brody B; Reilly-Harrington NA; Sylvia LG; Shesler LW; Bernstein EE; Schoenfeld D; Rabideau DJ; Leon AC; Faraone S; Thase ME
J Clin Psychiatry; 2016 Jan; 77(1):90-9. PubMed ID: 26845264
[TBL] [Abstract][Full Text] [Related]
20. Relationship between serum concentration and clinical response of quetiapine in adolescents and adults with bipolar disorders in acute stage: a prospective observational study.
Yang S; Zhang YF; Lu SJ; Ye ZQ; Lai JB; Li L; Yang X; Wang DD; Zhang PF; Wu LL; Huang HM; Gao XL; Wu M; Pan YM; Chen YQ; Zhang DH; Geng YM; Zhao QW; Hu SH
J Affect Disord; 2023 Mar; 324():199-205. PubMed ID: 36586603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]